COMPARATIVE VACCINE HESITANCY IN PEOPLE WITH COPD

TOPIC: Obstructive Lung Diseases TYPE: Original Investigations PURPOSE: To understand comparative vaccine (influenza, “pneumonia” and shingles) use reasons for hesitancy among people with COPD known to be at increased risk poor outcomes from preventable diseases.To the potential impact of a short educational video (the intervention) on self-reported shingles uptake intent interest. METHODS: An intervention study conducted in members Foundation’s Patient Powered Research Network (PPRN). All had COPD. A survey queried about receipt influenza, vaccines not receiving those vaccines. For individuals newest (shingles), 5-minute was presented discussing general disease burden COPD, prevention vaccination. 1-minute patient (COPD + testimonial included video. After viewing, participants were asked value RESULTS: 735 responded; 60% women, mean age 68.5 years, 53% reporting overall health 54% having >1 exacerbations past 12 months. Vaccination rates 93% pneumonia vaccines, 89% influenza 61% Health care recommendations varied by site: highest primary (61 91%) internet or family friends (35 47%) lower pulmonologists (21 61%) pharmacies (30 53%) attending specific site. The most common lack professional recommendation (7% >30% shingles), concerns side effects (pneumonia 22%, 38% 43%), inadequate information (influenza 11%, 20%, 32%) vaccines—fear causing (28% 22% respectively). Only 25% aware that developing shingles. felt useful (>94%) interest least their physician (>87%). Awareness 91%. CONCLUSIONS: Vaccine continues living particularly newer such as shingles.Health professionals’ are universal.A may have implications addressing COVID acceptance. CLINICAL IMPLICATIONS: Care must include clear burden, effectiveness accurate effect profiles all Professionals they visit. DISCLOSURES: Received funding GSK relationship GlaxoSmithKline Please note: 04/01/20-12/31/21 Added 04/30/2021 Elisabeth Callen, source=Web Response, value=Grant/Research Support No relevant relationships Janice Cotton, Response Natalia Loskutova, Sergio Martinez, Debora Merrill, Dennis Williams, Consultant $5001 - $20000 Barbara Yawn, value=Consulting fee Advisory Committee Member BI $1001 $5000 value=Honoraria AZ Sunovian Removed 02/15/2021 TEVA 11/2019-12/2021